Posts Tagged ‘Clinical research’

Oregon Partnership for Alzheimer’s Research Grant, applications due Mar. 5

The Oregon Partnership for Alzheimer’s Research (OPAR) has announced its 2013 Research Grant request for proposals, and is calling for investigators to submit proposals for one-year projects of up to $30,000. The OPAR anticipates funding three grants this cycle. Proposals are due March 5, 2013. Applications will be accepted from investigators in Oregon who are launching their careers, are established researchers exploring new areas of investigation, or, with appropriate mentoring, are doctoral level students. Applications will be … Read More

Reminder: Recruitment and Consent Discussions Brown Bag Session, Dec. 13

Thursday December 13 11:00 a.m. to 12:00 p.m. *please note early start time* OHSU Hospital, 8B60 Presenters: Triana Nagel and Trish Lindstrom The Office for Human Research Protections considers recruitment part of the consent process. Join us for a discussion and tips on how best to proceed wit: developing an effective recruitment plan and what is approvable by the IRB; new FDA guidance on advertisements; and the informed consent process – is your subject truly … Read More

IRB Notes: eIRB Helpdesk

Question: I’m trying to add Jane Doe to our study. She finished her modules last week but her name does not populate in the dropdown in eIRB. Why? Answer: She hasn’t registered for the eIRB system. It sounds obvious but it’s true—we get this question more frequently than you’d expect. Here’s how you can get started in the Electronic IRB system. To register, go to the main eIRB login page and click on “register here” … Read More

IRB Notes: Analyst notes on consent forms

Did you know that obtaining a signature on a consent form does not complete the consent process? Maintaining informed consent requires that subjects be provided with any new information that arises during the course of a study (such as changes to the research plan, change in risk/benefit profile, the results of related research, etc.) that may affect a subject’s decision whether or not to continue participation in the study. When such information arises, the investigator … Read More

Dennis McCarty, PhD, receives Lifetime Achievement Award

This month, Dennis McCarty, Ph.D., professor and vice chair of the Department of Public Health and Preventive Medicine, will be honored at the American Public Health Association’s 140th annual meeting with a Lifetime Achievement Award from the Alcohol, Tobacco, and Other Drugs Section. The award is meant to recognize an individual who has had a long and distinguished career in the field and has provided a lifetime of significant contributions. Dr. McCarty’s career has focused … Read More

Winter deadlines for American Heart research grants and fellowships

The American Heart Association has announced its winter deadlines for a wide range of funding opportunities relating to cardiovascular disease and stroke. All proposals and applications will be due either January 29th or 30th, 2013. Don’t forget that last year, the Association enacted new policies regarding membership and application fees. Find the full program descriptions below. American Heart Association – Winter 2013 Funding Opportunities National Scientist Development Grant– Up to $77,000 per year for up to four … Read More

Tomasz Beer, M.D., to join Dream Team for prostate cancer research

OHSU researcher and Knight Cancer Institute Deputy Director Tomasz Beer, M.D., has been selected to participate in a prestigious, six-person Dream Team to fight advanced-stage prostate cancer. Funding for this collaborative initiative is provided by Stand Up to Cancer, the Prostate Cancer Foundation, and the American Association for Cancer Research. Dr. Beer will be working with researchers from four University of California campuses–San Francisco, Los Angeles, Santa Crus, and Davis–as well as the University of … Read More

Doris Duke career development award for clinician scientists, LOI due Oct. 29

The Doris Duke Clinical Scientist Development Award Program provides junior physician-scientist faculty with $150,000 per year for up to three years to support mentored research in any disease area as they begin their careers as independent clinical investigators. To be eligible, applicants must: Hold a M.D., D.O., or foreign equivalent degree from an accredited institution; Have an active U.S. medical license – U.S. citizenship is not required; Have a full-time faculty position not higher than the … Read More

Pilot project funding for biomedical commercialization, LOIs due Nov. 1

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for Biomedical Innovation Program funding. The purpose of this funding opportunity is to accelerate the delivery of healthcare technologies from academia to the marketplace, thereby improving health care. This funding mechanism is offered in close collaboration with the School of Medicine Research Roadmap but is open to all OHSU faculty. All applicants are strongly encouraged to take advantage of … Read More

New partnership between OHSU and The Vancouver Clinic

OHSU’s Clinical and Translational Research Institute (OCTRI) and The Vancouver Clinic, are pleased to announce collaboration between the two institutions to facilitate research studies.  The collaboration is intended to enhance the ability to perform clinical research activities supported by a variety of funding sources (e.g., NIH, industry). Processes at both institutions, including IRB review, access to costing information, and access to patients for recruitment, have been streamlined to allow efficient access better serve to patient’s … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.